Dna methylation as a pharmacodynamic marker of glucocorticoid response and glioma survival

HIGHLIGHTS

• who: J. K. Wiencke from the Patient and control samples These glioma studies were approved by the Institutional Review Board of the University of California, San Francisco, Human Research Protection Program in the Office of Ethics and Compliance under UCSF Federal wide Assurance , and met all relevant ethical regulationsInformed consent was obtained from all study participants. The study design utilized a training dataset to develop predictors of DEX exposure and a test dataset to evaluate their performance Fig., a. The training dataset included , glioma subjects (, exposed to DEX have published the research: DNA methylation as a pharmacodynamic . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.